RITA COLELLA: Open Payments
NPI 1144493784 · CEDAR KNOLLS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 49 payments from 13 companies in 2025. Trend: 2023 $268 · 2024 $953 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $302 |
| Lilly USA, LLC | 7 | $221 |
| ABBVIE INC. | 7 | $218 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| Amgen Inc. | 4 | $63 |
| Exact Sciences Corporation | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Soleno Therapeutics, Inc. | 1 | $30 |
| Ardelyx, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
Products named: LINZESS, ZEPBOUND, Wegovy, Ozempic, MOUNJARO, Rybelsus, JARDIANCE, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
